Curcumin: Towards molecularly targeted chemoprevention of cancer

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Sanoff, 2014, Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer, J. Natl. Cancer Inst., 106, dju057, 10.1093/jnci/dju057 2013, Cancer Genomics: Molecular Classification, Prognosis and Response Prediction Koboldt, 2012, Comprehensive molecular portraits of human breast tumours, Nature, 490, 61, 10.1038/nature11412 Shlien, 2010, Copy number variations and cancer susceptibility, Curr. Opin. Oncol., 22, 55, 10.1097/CCO.0b013e328333dca4 Wain, 2009, Genomic copy number variation, human health, and disease, Lancet, 374, 340, 10.1016/S0140-6736(09)60249-X Easton, 2007, Genome-wide association study identifies novel breast cancer susceptibility loci, Nature, 447, 1087, 10.1038/nature05887 Hunter, 2007, A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer, Nat. Genet., 39, 870, 10.1038/ng2075 Gold, 2008, Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33, Proc. Natl. Acad. Sci. USA, 105, 4340, 10.1073/pnas.0800441105 Stacey, 2008, Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer, Nat. Genet., 40, 703, 10.1038/ng.131 Visvanathan, 2013, Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline, J. Clin. Oncol., 31, 2942, 10.1200/JCO.2013.49.3122 Waters, 2010, Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women, Cancer Epidemiol. Biomark. Prev., 19, 443, 10.1158/1055-9965.EPI-09-0930 Gronich, 2013, Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates, Nat. Rev. Clin. Oncol., 10, 625, 10.1038/nrclinonc.2013.169 Bachmeier, 2010, Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin, Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol., 26, 471, 10.1159/000320570 Liao, 2012, Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival, N. Engl. J. Med., 367, 1596, 10.1056/NEJMoa1207756 Albini, 2010, Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs, Clin. Exp. Metastasis, 27, 419, 10.1007/s10585-010-9312-5 Albini, 2012, Cancer prevention by targeting angiogenesis, Nat. Rev. Clin. Oncol., 9, 498, 10.1038/nrclinonc.2012.120 Yue, 2014, Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment, Cancer Prev. Res. (Phila), 7, 388, 10.1158/1940-6207.CAPR-13-0337 Marini, 2013, Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer, Cell Cycle, 12, 3490, 10.4161/cc.26461 Semba, 2014, REsveratrol levels and all-cause mortality in older community-dwelling adults, JAMA Intern. Med., 10.1001/jamainternmed.2014.1582 Kunnumakkara, 2008, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins, Cancer Lett., 269, 199, 10.1016/j.canlet.2008.03.009 Hatcher, 2008, Curcumin: from ancient medicine to current clinical trials, Cell. Mol. Life Sci., 65, 1631, 10.1007/s00018-008-7452-4 Bachmeier, 2010, Novel aspects for the application of Curcumin in chemoprevention of various cancers, Front. Biosci., 2, 697, 10.2741/s95 Bharti, 2003, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis, Blood, 101, 1053, 10.1182/blood-2002-05-1320 Killian, 2012, Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2, Carcinogenesis, 33, 2507, 10.1093/carcin/bgs312 Kronski, 2014, miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2, Mol. Oncol., 8, 581, 10.1016/j.molonc.2014.01.005 Perkins, 2007, Integrating cell-signalling pathways with NF-kappaB and IKK function, Nat. Rev. Mol. Cell. Biol., 8, 49, 10.1038/nrm2083 Karin, 2006, Nuclear factor-kappaB in cancer development and progression, Nature, 441, 431, 10.1038/nature04870 Bachmeier, 2008, Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB, Carcinogenesis, 29, 779, 10.1093/carcin/bgm248 Beevers, 2009, Curcumin disrupts the Mammalian target of rapamycin-raptor complex, Cancer Res., 69, 1000, 10.1158/0008-5472.CAN-08-2367 Zhou, 2007, The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro, Lab. Invest., 87, 488, 10.1038/labinvest.3700532 Pan, 2008, AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells, Oncol. Rep., 20, 1553 Leu, 2003, Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity, Biochem. Pharmacol., 66, 2323, 10.1016/j.bcp.2003.08.017 Prakobwong, 2011, Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways, Carcinogenesis, 32, 1372, 10.1093/carcin/bgr032 Robertson, 2010, Inflammatory breast cancer: the disease, the biology, the treatment, CA Cancer J. Clin., 60, 351, 10.3322/caac.20082 Yamaguchi, 2009, Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines, Cancer Sci., 100, 1668, 10.1111/j.1349-7006.2009.01228.x Bachmeier, 2007, The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice, Cell Physiol. Biochem., 19, 137, 10.1159/000099202 Slattery, 2012, Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population, Carcinogenesis, 33, 1512, 10.1093/carcin/bgs163 Nelson, 2002, The diet, prostate inflammation, and the development of prostate cancer, Cancer Metastasis Rev., 21, 3, 10.1023/A:1020110718701 Sfanos, 2012, Prostate cancer and inflammation: the evidence, Histopathology, 60, 199, 10.1111/j.1365-2559.2011.04033.x Nguyen, 2006, BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation, J. Immunol., 176, 7354, 10.4049/jimmunol.176.12.7354 Fitzgerald, 2013, Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility, Cancer Epidemiol. Biomarkers Prev., 22, 1520, 10.1158/1055-9965.EPI-13-0345 Garcea, 2005, Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences, Cancer Epidemiol. Biomarkers Prev., 14, 120, 10.1158/1055-9965.120.14.1 Wang, 2010, The role of COX-2 in intestinal inflammation and colorectal cancer, Oncogene, 29, 781, 10.1038/onc.2009.421 Johnson, 2007, Curcumin for chemoprevention of colon cancer, Cancer Lett., 255, 170, 10.1016/j.canlet.2007.03.005 Curtin, 2010, Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor, BMC Med. Genet., 11, 170, 10.1186/1471-2350-11-170 Weedon, 2008, Genome-wide association analysis identifies 20 loci that influence adult height, Nat. Genet., 40, 575, 10.1038/ng.121